As of 2024-12-15, the EV/EBITDA ratio of Inari Medical Inc (NARI) is -95.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NARI's latest enterprise value is 3,213.10 mil USD. NARI's TTM EBITDA according to its financial statements is -33.52 mil USD. Dividing these 2 quantities gives us the above NARI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 16.1x | 13.2x |
| Forward P/E multiples | 15.5x - 25.2x | 17.2x |
| Fair Price | (8.19) - (8.54) | (8.00) |
| Upside | -114.7% - -115.4% | -114.4% |
| Date | EV/EBITDA |
| 2024-12-13 | -95.87 |
| 2024-12-12 | -97.20 |
| 2024-12-11 | -100.44 |
| 2024-12-10 | -94.92 |
| 2024-12-09 | -92.02 |
| 2024-12-06 | -87.99 |
| 2024-12-05 | -88.83 |
| 2024-12-04 | -89.95 |
| 2024-12-03 | -88.81 |
| 2024-12-02 | -89.81 |
| 2024-11-29 | -89.46 |
| 2024-11-27 | -87.90 |
| 2024-11-26 | -87.55 |
| 2024-11-25 | -85.20 |
| 2024-11-22 | -85.51 |
| 2024-11-21 | -85.67 |
| 2024-11-20 | -84.36 |
| 2024-11-19 | -87.80 |
| 2024-11-18 | -88.41 |
| 2024-11-15 | -87.08 |
| 2024-11-14 | -84.78 |
| 2024-11-13 | -87.45 |
| 2024-11-12 | -88.37 |
| 2024-11-11 | -91.96 |
| 2024-11-08 | -88.53 |
| 2024-11-07 | -89.32 |
| 2024-11-06 | -91.82 |
| 2024-11-05 | -86.19 |
| 2024-11-04 | -84.24 |
| 2024-11-01 | -83.90 |
| 2024-10-31 | -83.31 |
| 2024-10-30 | -81.04 |
| 2024-10-29 | -84.67 |
| 2024-10-28 | -73.11 |
| 2024-10-25 | -75.10 |
| 2024-10-24 | -75.55 |
| 2024-10-23 | -75.82 |
| 2024-10-22 | -76.39 |
| 2024-10-21 | -75.40 |
| 2024-10-18 | -76.03 |
| 2024-10-17 | -74.70 |
| 2024-10-16 | -76.32 |
| 2024-10-15 | -77.13 |
| 2024-10-14 | -72.48 |
| 2024-10-11 | -71.78 |
| 2024-10-10 | -69.74 |
| 2024-10-09 | -71.59 |
| 2024-10-08 | -72.83 |
| 2024-10-07 | -69.72 |
| 2024-10-04 | -71.99 |